RH Bophelo Limited (JSE:RHB)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 188.00
0.00 (0.00%)
Jul 1, 2025, 4:40 PM SAST
RH Bophelo Revenue
In the fiscal year ending February 28, 2025, RH Bophelo had annual revenue of 111.89M ZAR, down -60.72%. RH Bophelo had revenue of 59.41M in the half year ending February 28, 2025, a decrease of -279.48%.
Revenue
111.89M
Revenue Growth
-60.72%
P/S Ratio
1.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
121.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 111.89M | -172.97M | -60.72% |
| Feb 29, 2024 | 284.86M | 300.68M | -1,899.82% |
| Feb 28, 2023 | -15.83M | -106.06M | -117.54% |
| Feb 28, 2022 | 90.24M | -99.03M | -52.32% |
| Feb 28, 2021 | 189.27M | 81.69M | 75.94% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clicks Group | 46.80B |
| Aspen Pharmacare Holdings | 45.53B |
| Dis-Chem Pharmacies | 39.17B |
| Life Healthcare Group Holdings | 26.73B |
| Netcare | 25.85B |
| Adcock Ingram Holdings | 9.62B |
| AfroCentric Investment Corporation | 8.81B |
| Ascendis Health | 734.49M |